(G) Genpact - Ratings and Ratios
Business Process Outsourcing, IT Services, Digital Operations
G EPS (Earnings per Share)
G Revenue
Description: G Genpact
Genpact Limited is a global business process outsourcing and information technology services company operating across multiple regions, including India, Asia, North and Latin America, and Europe. The company is divided into three main segments: Financial Services, Consumer and Healthcare, and High Tech and Manufacturing, offering a wide range of services tailored to each industry.
The Financial Services segment provides comprehensive services, including customer onboarding, loan operations, payment processing, wealth management, and financial crime risk management. The Consumer and Healthcare segment focuses on demand generation, supply chain management, customer experience, and healthcare services such as claims processing and revenue cycle management. The High Tech and Manufacturing segment delivers industry-specific solutions, including trust and safety, customer care support, supply chain management, and engineering services.
From a financial perspective, Genpact has demonstrated solid performance. With a market capitalization of $7.934 billion, the company has a price-to-earnings ratio of 15.43 and a forward P/E of 18.32, indicating moderate growth expectations. The return on equity stands at 22.04%, suggesting efficient use of shareholder capital. Key performance indicators (KPIs) to watch include revenue growth, operating margin expansion, and cash flow generation, which are crucial for a services company like Genpact.
Analyzing the companys operational efficiency, metrics such as days sales outstanding (DSO), employee utilization rates, and client retention rates are important. Additionally, the growth in digital transformation services, including data analytics and AI, is a significant driver for Genpact, given the increasing demand for such services across its client base. The companys ability to expand its service offerings and maintain a strong global presence will be critical for its future growth.
Investors should also consider Genpacts competitive positioning within the business process outsourcing (BPO) and IT services industry, its ability to attract and retain top talent, and its strategy for leveraging technology to drive innovation and efficiency. Monitoring these factors, along with the companys financial health and operational performance, will be essential for assessing its potential for long-term success.
G Stock Overview
| Market Cap in USD | 7,877m |
| Sub-Industry | Data Processing & Outsourced Services |
| IPO / Inception | 2007-08-02 |
G Stock Ratings
| Growth Rating | 8.77% |
| Fundamental | 84.7% |
| Dividend Rating | 52.7% |
| Return 12m vs S&P 500 | -7.84% |
| Analyst Rating | 3.91 of 5 |
G Dividends
| Dividend Yield 12m | 1.54% |
| Yield on Cost 5y | 1.79% |
| Annual Growth 5y | 9.32% |
| Payout Consistency | 56.9% |
| Payout Ratio | 19.1% |
G Growth Ratios
| Growth Correlation 3m | 5.1% |
| Growth Correlation 12m | 26.4% |
| Growth Correlation 5y | -8.1% |
| CAGR 5y | -1.27% |
| CAGR/Max DD 3y | -0.04 |
| CAGR/Mean DD 3y | -0.07 |
| Sharpe Ratio 12m | 0.22 |
| Alpha | -1.50 |
| Beta | 0.475 |
| Volatility | 27.21% |
| Current Volume | 1521.2k |
| Average Volume 20d | 1706.1k |
| Stop Loss | 40.8 (-3.1%) |
| Signal | -0.84 |
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income (538.3m TTM) > 0 and > 6% of Revenue (6% = 295.7m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 1.74pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.07% (prev 23.28%; Δ -8.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 649.5m > Net Income 538.3m (YES >=105%, WARN >=100%) |
| Net Debt (868.3m) to EBITDA (880.0m) ratio: 0.99 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.53 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (177.1m) change vs 12m ago -2.13% (target <= -2.0% for YES) |
| Gross Margin 35.63% (prev 35.37%; Δ 0.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 94.01% (prev 88.63%; Δ 5.38pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.98 (EBITDA TTM 880.0m / Interest Expense TTM 79.1m) >= 6 (WARN >= 3) |
Altman Z'' 3.00
| (A) 0.14 = (Total Current Assets 2.14b - Total Current Liabilities 1.39b) / Total Assets 5.31b |
| (B) 0.25 = Retained Earnings (Balance) 1.35b / Total Assets 5.31b |
| (C) 0.15 = EBIT TTM 789.0m / Avg Total Assets 5.24b |
| (D) 0.23 = Book Value of Equity 621.6m / Total Liabilities 2.72b |
| Total Rating: 3.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.74
| 1. Piotroski 9.50pt = 4.50 |
| 2. FCF Yield 6.57% = 3.29 |
| 3. FCF Margin 11.43% = 2.86 |
| 4. Debt/Equity 0.53 = 2.37 |
| 5. Debt/Ebitda 1.54 = 0.88 |
| 6. ROIC - WACC 9.00% = 11.25 |
| 7. RoE 21.92% = 1.83 |
| 8. Rev. Trend 93.33% = 4.67 |
| 9. Rev. CAGR 4.51% = 0.56 |
| 10. EPS Trend 77.88% = 1.95 |
| 11. EPS CAGR 5.98% = 0.60 |
What is the price of G shares?
Over the past week, the price has changed by -4.50%, over one month by -3.17%, over three months by -3.62% and over the past year by +9.57%.
Is Genpact a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of G is around 39.18 USD . This means that G is currently overvalued and has a potential downside of -6.96%.
Is G a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the G price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 52.4 | 24.5% |
| Analysts Target Price | 52.4 | 24.5% |
| ValueRay Target Price | 43 | 2.1% |
Last update: 2025-09-05 04:44
G Fundamental Data Overview
CCE Cash And Equivalents = 663.3m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 15.0166
P/E Forward = 18.315
P/S = 1.5981
P/B = 3.0453
P/EG = 1.7
Beta = 0.928
Revenue TTM = 4.93b USD
EBIT TTM = 789.0m USD
EBITDA TTM = 880.0m USD
Long Term Debt = 833.4m USD (from longTermDebt, last quarter)
Short Term Debt = 525.0m USD (from shortTermDebt, last quarter)
Debt = 1.36b USD (Calculated: Short Term 525.0m + Long Term 833.4m)
Net Debt = 868.3m USD (from netDebt column, last quarter)
Enterprise Value = 8.57b USD (7.88b + Debt 1.36b - CCE 663.3m)
Interest Coverage Ratio = 9.98 (Ebit TTM 789.0m / Interest Expense TTM 79.1m)
FCF Yield = 6.57% (FCF TTM 563.4m / Enterprise Value 8.57b)
FCF Margin = 11.43% (FCF TTM 563.4m / Revenue TTM 4.93b)
Net Margin = 10.92% (Net Income TTM 538.3m / Revenue TTM 4.93b)
Gross Margin = 35.63% ((Revenue TTM 4.93b - Cost of Revenue TTM 3.17b) / Revenue TTM)
Tobins Q-Ratio = 13.79 (Enterprise Value 8.57b / Book Value Of Equity 621.6m)
Interest Expense / Debt = 1.33% (Interest Expense 18.0m / Debt 1.36b)
Taxrate = 24.11% (163.2m / 676.8m)
NOPAT = 598.8m (EBIT 789.0m * (1 - 24.11%))
Current Ratio = 1.53 (Total Current Assets 2.14b / Total Current Liabilities 1.39b)
Debt / Equity = 0.53 (Debt 1.36b / last Quarter total Stockholder Equity 2.59b)
Debt / EBITDA = 1.54 (Net Debt 868.3m / EBITDA 880.0m)
Debt / FCF = 2.41 (Debt 1.36b / FCF TTM 563.4m)
Total Stockholder Equity = 2.46b (last 4 quarters mean)
RoA = 10.14% (Net Income 538.3m, Total Assets 5.31b )
RoE = 21.92% (Net Income TTM 538.3m / Total Stockholder Equity 2.46b)
RoCE = 23.99% (Ebit 789.0m / (Equity 2.46b + L.T.Debt 833.4m))
RoIC = 15.78% (NOPAT 598.8m / Invested Capital 3.80b)
WACC = 6.78% (E(7.88b)/V(9.24b) * Re(7.77%)) + (D(1.36b)/V(9.24b) * Rd(1.33%) * (1-Tc(0.24)))
Shares Correlation 3-Years: -90.91 | Cagr: -0.51%
Discount Rate = 7.77% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 79.55% ; FCFE base≈521.9m ; Y1≈571.0m ; Y5≈725.2m
Fair Price DCF = 72.45 (DCF Value 12.63b / Shares Outstanding 174.3m; 5y FCF grow 10.74% → 3.0% )
EPS Correlation: 77.88 | EPS CAGR: 5.98% | SUE: 1.30 | # QB: True
Revenue Correlation: 93.33 | Revenue CAGR: 4.51%
Additional Sources for G Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle